Tenet Healthcare (THC)
(Delayed Data from NYSE)
$165.84 USD
+1.17 (0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $165.85 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$165.84 USD
+1.17 (0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $165.85 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
Zacks News
Universal Health (UHS) Gains From Solid Segmental Performance
by Zacks Equity Research
Universal Health (UHS) gains from the uptrend in revenue growth, which in turn, is derived from expanding patient volumes. A credible financial position drives its expansion endeavors.
Encompass Health's (EHC) Q2 Earnings Beat, '23 EPS View Raised
by Zacks Equity Research
Encompass Health's (EHC) Q2 results reflect a growing patient base and improved net patient revenue per discharge. Management anticipates 2023 adjusted EPS within $3.31-$3.53, up from the earlier view of $2.94-$3.23.
Tenet Healthcare (THC) Q2 Earnings Beat on Solid Hospital Unit
by Zacks Equity Research
Tenet Healthcare's (THC) Q2 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.18-$6.03 for this year.
Compared to Estimates, Tenet (THC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Tenet Healthcare (THC) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 14.29% and 3.70%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Acadia Healthcare (ACHC) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 10.84% and 3.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Conifer Weakness Affect Tenet Healthcare's (THC) Q2 Earnings?
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter results are likely to reflect higher Ambulatory Care operating revenues and supply costs.
Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $77.20 in the latest trading session, marking a +0.4% move from the prior day.
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $80.37 in the latest trading session, marking a -0.1% move from the prior day.
Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
All You Need to Know About Tenet (THC) Rating Upgrade to Strong Buy
by Zacks Equity Research
Tenet (THC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
4 Hospital Stocks in Focus Amid Improving Industry Trends
by Kaibalya Pravo Dey
Delayed elective procedures are boosting patient volumes for the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Tenet Healthcare (THC) and Community Health (CYH) are poised to gain from improving occupancy rates.
Universal Health (UHS) Gains 3.7% as Pent-Up Surgeries Rise
by Zacks Equity Research
The pent-up demand for elective surgeries is expected to improve Universal Health's (UHS) patient admissions and patient days.
Universal Health Services (UHS) Surges 3.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Universal Health Services (UHS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Community Health Systems (CYH) Down 16% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare (THC) Gains 42.1% YTD: More Room to Run?
by Zacks Equity Research
Tenet Healthcare's (THC) aim to boost USPI's network through continuous buyouts is positioning the company well for growth.
Tenet (THC) Down 3.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
Here's Why You Should Hold Molina (MOH) in Your Portfolio
by Zacks Equity Research
Molina's (MOH) inorganic growth activities, financial flexibility and well-performing Medicaid and Medicare segments poise it for growth.
Tenet (THC) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Community Health (CYH) Stock Down 41.9% Since Q1 Earnings Release
by Zacks Equity Research
Community Health's (CYH) Q1 results reflect deteriorating metrics like patient days, length of stay and occupancy rates. However, rising admissions partially offset the negatives.
Tenet Healthcare's (THC) Q1 Earnings Beat, Shares Up 3.9%
by Zacks Equity Research
Tenet Healthcare's (THC) first-quarter 2023 results gain on increased patient volumes. Management presently expects adjusted EPS within $4.92-$6.09 in 2023, up from the prior view of $4.68-$5.85.
Compared to Estimates, Tenet (THC) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.